These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 7554168)

  • 21. Lymphatic filariasis in India: epidemiology and control measures.
    Raju K; Jambulingam P; Sabesan S; Vanamail P
    J Postgrad Med; 2010; 56(3):232-8. PubMed ID: 20739779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filariasis and its control in Fujian, China.
    Liu JY; Liu XJ; Chen Z; Tu ZP; Zheng GB; Chen YN; Zhang YZ; Weng SP; Huang XH; Yang FZ
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):147-54. PubMed ID: 1948271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
    Houston R
    Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control and surveillance of filariasis in Shandong.
    Zhong CH; Zhen TM
    Chin Med J (Engl); 1991 Mar; 104(3):179-85. PubMed ID: 2065525
    [No Abstract]   [Full Text] [Related]  

  • 25. A successful control programme for lymphatic filariasis in Hubei, China.
    Zhang S; Cheng F; Webber R
    Trans R Soc Trop Med Hyg; 1994; 88(5):510-2. PubMed ID: 7992323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A brief introduction to the research achievement on the strategy and technical measures for interrupting the transmission of lymphatic filariasis in China.
    Shi ZJ; Sun DJ; Wang ZJ; Tao ZH; Pan SX; Liu XJ; Zhang SQ; Ou ZY; Zhu SZ; Li QJ; Chang J; Wu RZ; Deng SS; Zheng XQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(2):110-2. PubMed ID: 12572001
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic tools for filariasis elimination programs.
    Weil GJ; Ramzy RM
    Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor influencing acceptance and non-acceptance to DEC in a bancroftian endemic area.
    Sunny PJ; Jain DC; Sorrian TP; Ghosh TK
    J Commun Dis; 1986 Dec; 18(4):317-9. PubMed ID: 3309041
    [No Abstract]   [Full Text] [Related]  

  • 31. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of disease and infection of lymphatic filariasis in Northeastern Cambodia.
    Leang R; Socheat D; Bin B; Bunkea T; Odermatt P
    Trop Med Int Health; 2004 Oct; 9(10):1115-20. PubMed ID: 15482405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
    J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diethylcarbamazine salt in the control of lymphatic filariasis.
    Gelband H
    Am J Trop Med Hyg; 1994 Jun; 50(6):655-62. PubMed ID: 8024057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of imported bancroftian filariasis after two-year multiple-dose diethylcarbamazine treatment.
    Koyadun S; Bhumiratana A
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):822-31. PubMed ID: 16295532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
    Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
    P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling the epidemiology, transmission and control of lymphatic filariasis.
    Das PK; Subramanian S
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil.
    Schlemper BR; Steindel M; Grisard EC; Carvalho-Pinto CJ; Bernardini OJ; de Castilho CV; Rosa G; Kilian S; Guarneri AA; Rocha A; Medeiros Z; Ferreira Neto JA
    Trop Med Int Health; 2000 Dec; 5(12):848-54. PubMed ID: 11169273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.